Paul Leger

Paul Leger

Scientist Ii Medicinal Chemistry @ Rapt Therapeutics

About Paul Leger

Paul Leger is a Scientist II in Medicinal Chemistry at RAPT Therapeutics, where he contributes to the design and synthesis of small molecules for immuno-oncology programs. He holds a PhD in Organic Chemistry from the University of California, Berkeley, and a BA in Chemistry from Grinnell College.

Work at RAPT Therapeutics

Paul Leger currently holds the position of Scientist II in Medicinal Chemistry at RAPT Therapeutics, a role he has occupied since 2020. His work is part of a collaborative team focused on developing next-generation therapeutics. Previously, he served as a Scientist in Medicinal Chemistry at the same organization from 2017 to 2019. During his tenure, he contributed to the design and synthesis of small molecules for various programs within the immuno-oncology pipeline.

Education and Expertise

Paul Leger earned his Doctor of Philosophy (PhD) in Organic Chemistry from the University of California, Berkeley, where he studied from 2012 to 2016. Prior to this, he obtained a Bachelor of Arts (B.A.) in Chemistry from Grinnell College, studying there from 2008 to 2012. His educational background provides a strong foundation for his expertise in medicinal chemistry and drug development.

Background

Paul Leger has a solid academic and professional background in chemistry and medicinal chemistry. He began his higher education at Grinnell College, where he completed his undergraduate studies in Chemistry. He then advanced to the University of California, Berkeley, to pursue a PhD in Organic Chemistry. His career in the pharmaceutical industry includes significant experience at RAPT Therapeutics, where he has been involved in innovative therapeutic development.

Achievements

Throughout his career at RAPT Therapeutics, Paul Leger has made contributions to the design and synthesis of small molecules aimed at enhancing immuno-oncology treatments. His role as a Scientist II in Medicinal Chemistry highlights his ongoing commitment to advancing therapeutic options in the field. His work reflects a dedication to scientific research and collaboration within a fast-paced environment.

People similar to Paul Leger